Cargando…
Modulation of the Cellular Expression of Circulating Advanced Glycation End-Product Receptors in Type 2 Diabetic Nephropathy
Background. Advanced glycation end-products (AGEs) and their receptors are prominent contributors to diabetic kidney disease. Methods. Flow cytometry was used to measure the predictive capacity for kidney impairment of the AGE receptors RAGE, AGE-R1, and AGE-R3 on peripheral blood mononuclear cells...
Autores principales: | Sourris, Karly C., Harcourt, Brooke E., Penfold, Sally A., Yap, Felicia Y. T., Morley, Amy L., Morgan, Philip E., Davies, Michael J., Baker, Scott T., Jerums, George, Forbes, Josephine M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034946/ https://www.ncbi.nlm.nih.gov/pubmed/21318189 http://dx.doi.org/10.1155/2010/974681 |
Ejemplares similares
-
Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion
por: Zhuang, Aowen, et al.
Publicado: (2019) -
The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition)
por: Zhuang, Aowen, et al.
Publicado: (2021) -
Processed foods drive intestinal barrier permeability and microvascular diseases
por: Snelson, Matthew, et al.
Publicado: (2021) -
Advanced Glycation End Products Are Direct Modulators of β-Cell Function
por: Coughlan, Melinda T., et al.
Publicado: (2011) -
Advanced glycation end products, oxidative stress and diabetic nephropathy
por: Yamagishi, Sho-ichi, et al.
Publicado: (2010)